Accéder au contenu
Merck

Accurate in vivo tumor detection using plasmonic-enhanced shifted-excitation Raman difference spectroscopy (SERDS).

Theranostics (2021-03-24)
Pietro Strobbia, Vanessa Cupil-Garcia, Bridget M Crawford, Andrew M Fales, T Joshua Pfefer, Yang Liu, Martin Maiwald, Bernd Sumpf, Tuan Vo-Dinh
RÉSUMÉ

For the majority of cancer patients, surgery is the primary method of treatment. In these cases, accurately removing the entire tumor without harming surrounding tissue is critical; however, due to the lack of intraoperative imaging techniques, surgeons rely on visual and physical inspection to identify tumors. Surface-enhanced Raman scattering (SERS) is emerging as a non-invasive optical alternative for intraoperative tumor identification, with high accuracy and stability. However, Raman detection requires dark rooms to work, which is not consistent with surgical settings. Methods: Herein, we used SERS nanoprobes combined with shifted-excitation Raman difference spectroscopy (SERDS) detection, to accurately detect tumors in xenograft murine model. Results: We demonstrate for the first time the use of SERDS for in vivo tumor detection in a murine model under ambient light conditions. We compare traditional Raman detection with SERDS, showing that our method can improve sensitivity and accuracy for this task. Conclusion: Our results show that this method can be used to improve the accuracy and robustness of in vivo Raman/SERS biomedical application, aiding the process of clinical translation of these technologies.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
3,3′-Diethylthiatricarbocyanine iodide, 99%